Alere Inc. (NYSE:ALR) has released results from a study that shows heart patients benefit from a self-test to monitor B-type natriuretic peptide (BNP) levels. © 2025 ...
LOWELL, Mass.--(BUSINESS WIRE)--DiagnosisOne, an Alere subsidiary specializing in analytics and clinical decision support technology, today announced that the Company will now be conducting business ...
PHILADELPHIA--(BUSINESS WIRE)--CLEU Diagnostics, the company reimagining comprehensive clinical laboratory testing has expanded its team with the addition of Nigel Lindner, PhD as Chief Innovation ...
(Reuters) - Alere Inc's former Chief Executive Ron Zwanziger said he intends to take the diagnostic device and service provider private in a deal that values the company at $3.82 billion. Zwanziger ...
Oct 24 (Reuters) - Inverness Medical Innovations Inc said it agreed to acquire Alere Medical Inc, a specialized health management company, for $302 million in cash and stock, to enter the disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback